The OSOM® COVID-19 Test is a CLIA-waived point-of-care test designed for the qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen in direct anterior nasal swab specimens from individuals with signs and symptoms of upper respiratory infection within the first 4 days of symptom onset.
Pricing and ordering details are determined by several factors. Please provide your contact information and we will be in touch shortly with more detailed product information.
Related Products
Name
Category
Type
OSOM® RSV Test
Point-of-Care Testing
Rapid Tests
The Metrix® COVID/Flu Test
Point-of-Care Testing
Molecular
OSOM® Flu SARS-CoV-2 Combo Test
Point-of-Care Testing
Rapid Tests
Get in Touch
When you’re ready to order, we’re here to help.
Fill out the form below and someone from our team will get back to you shortly.